Clinical Trials
61 trialsBACCHUS
University Hospital, Lille
CRC-ORGA2
University Hospital, Grenoble
Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas
University of Michigan Rogel Cancer Center
A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials
University of Florida
Genomic Services Research Program
National Institutes of Health Clinical Center (CC)
iCaRe2
University of Nebraska
ACROBATICC
Helse Stavanger HF
Clinicopathological Characteristics of Colon Cancer in Young Age
Seoul National University Bundang Hospital
DEMETRA
San Raffaele University
ACBC
Skane University Hospital
Collection of Blood From Patients With Cancer
National Institutes of Health Clinical Center (CC)
The Utility and Feasibility of Mt-sDNA as a Surveillance Procedure in Colorectal Cancer Survivors
Case Comprehensive Cancer Center
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
National Institutes of Health Clinical Center (CC)
ASAP
Avera McKennan Hospital & University Health Center
LICOSARH
Aesculap AG
(CLOCS-2)
Imperial College London
SOLAR
Guardant Health, Inc.
PRO-ACTIVE
Fondazione del Piemonte per l'Oncologia
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
Memorial Sloan Kettering Cancer Center
Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients
Vanderbilt University Medical Center
BEACON
San Raffaele University
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Washington University School of Medicine
Neoadjuvant Therapy With Tislelizumab for dMMR/MSI-H Stage II-III Colorectal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
ENCODE
City of Hope Medical Center
COLON-MD
Baylor Research Institute
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Memorial Sloan Kettering Cancer Center
EXoPERT EMERALD Clinical Study
EXoPERT
Comprehensive Analysis of Gut Microbiota Signatures in Metastatic Colorectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University
Identification of New Non-invasive, Predictive, and Diagnostic Biomarkers for Colorectal Cancer
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis
FIND-CRC
Natera, Inc.
EXPOSE
City of Hope Medical Center
LIBERATE
University Health Network, Toronto
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
Endoscopic Resection of Gastrointestinal Neoplasms
Azienda USL Reggio Emilia - IRCCS
FECCo
University Hospital, Limoges
ctdna-GI
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
CASCADE
Epiliquid Holding, Inc
eAArly DETECT
Mainz Biomed
CROSS
Bordeaux Colorectal Institute Academy
French Assessment of MRD by Liquid Biopsies in Stage III CRC Patients (FRENCH.MRD.CRC)
University Hospital, Montpellier
AACRC
City of Hope Medical Center
Hi-STEP1
Technische Universität Dresden
HEBE
Niguarda Hospital
Mesogastrium Metastasis in Colon Cancer
Tongji Hospital
AE Registry
Centre hospitalier de l'Université de Montréal (CHUM)
AIR-REC
NHS Greater Glasgow and Clyde
PROCEED-CRC
Natera, Inc.
Development of Organoids From Primary Colorectal Tumors and Synchronous Liver Metastases
Regina Elena Cancer Institute
Effect of Gut Microbiota and Its Metabolites on the Efficacy of Immunotherapy in Metastatic Colorectal Cancer
The First Hospital of Jilin University
EVIDENCE
Imperial College London